CDC50A and prostate carcinoma: Later, Romanuik et al. [58, 59] detected the increase of TMEM30A transcript level in patients with primary prostate cancer, and its gene expression trend was consistent with the existence of proliferating cells in castration-recurrent prostate cancer (CRPC).